Provided by Tiger Fintech (Singapore) Pte. Ltd.

Intra-Cellular Therapies

131.87
+0.0000
Volume:- -
Turnover:- -
Market Cap:14.02B
PE:-182.12
High:131.87
Open:131.87
Low:131.87
Close:131.87
Loading ...
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 22, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities